UNH icon

UnitedHealth

303.26 USD
+2.83
0.94%
Updated Aug 27, 10:04 AM EDT
1 day
0.94%
5 days
0.32%
1 month
7.49%
3 months
2.80%
6 months
-35.28%
Year to date
-39.89%
1 year
-48.37%
5 years
-2.70%
10 years
157.50%
 

About: UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Employees: 400,000

0
Funds holding %
of 7,434 funds
0
Analysts bullish %
of 14 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

20% more call options, than puts

Call options by funds: $10.5B | Put options by funds: $8.71B

10% less repeat investments, than reductions

Existing positions increased: 1,262 | Existing positions reduced: 1,402

2.47% less ownership

Funds ownership: 87.1% [Q1] → 84.63% (-2.47%) [Q2]

13% less funds holding

Funds holding: 3,552 [Q1] → 3,100 (-452) [Q2]

43% less capital invested

Capital invested by funds: $417B [Q1] → $239B (-$178B) [Q2]

58% less first-time investments, than exits

New positions opened: 268 | Existing positions closed: 640

67% less funds holding in top 10

Funds holding in top 10: 223 [Q1] → 73 (-150) [Q2]

Research analyst outlook

14 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$198
35%
downside
Avg. target
$322
6%
upside
High target
$440
45%
upside

14 analyst ratings

12 positive
86%
neutral
7%
negative
7%
Cantor Fitzgerald
Sarah James
45%upside
$440
Overweight
Reiterated
26 Aug 2025
Morgan Stanley
Ricky Goldwasser
7%upside
$325
Overweight
Maintained
20 Aug 2025
B of A Securities
Kevin Fischbeck
7%upside
$325
Neutral
Maintained
18 Aug 2025
Mizuho
Ann Hynes
1%downside
$300
Outperform
Maintained
7 Aug 2025
JP Morgan
Lisa Gill
2%upside
$310
Overweight
Maintained
6 Aug 2025

Financial journalist opinion

Based on 242 articles about UNH published over the past 30 days

Positive
Seeking Alpha
1 hour ago
UnitedHealth: A Generational Buying Opportunity
UnitedHealth's stock sell-off is overdone; the current valuation reflects temporary setbacks, not a structural decline, creating a generational buying opportunity. UNH's integrated insurance and healthcare model, market dominance, and irreplaceable role in the US system underpin long-term growth potential. Management's pricing strategy and projected EPS growth support a rebound in margins and justify a Strong Buy rating at current levels.
UnitedHealth: A Generational Buying Opportunity
Negative
PYMNTS
14 hours ago
Justice Department Investigates UnitedHealth Group Pharmacy Business and Doctor Reimbursements
A Justice Department criminal investigation of UnitedHealth Group is reportedly broader than initially thought. Bloomberg reported Tuesday (Aug.
Justice Department Investigates UnitedHealth Group Pharmacy Business and Doctor Reimbursements
Negative
Benzinga
17 hours ago
UnitedHealth Stock Falls As Department Of Justice Criminal Probe Expands To Optum Rx: Report
UnitedHealth Group Inc UNH shares closed Tuesday's session lower following a Bloomberg report suggesting a U.S. Department of Justice criminal probe into the company is broader than previously known, according to people familiar with the matter.
UnitedHealth Stock Falls As Department Of Justice Criminal Probe Expands To Optum Rx: Report
Negative
Reuters
17 hours ago
DoJ digging into UnitedHealth's prescription management services, Bloomberg News reports
The U.S. Justice Department's criminal division is digging into business practices at UnitedHealth Group's pharmacy benefit manager, Bloomberg News reported on Tuesday, citing people familiar with the matter.
DoJ digging into UnitedHealth's prescription management services, Bloomberg News reports
Positive
Zacks Investment Research
21 hours ago
UnitedHealth's Misdiagnosis: Can Berkshire's Bet Spark a Recovery?
Berkshire's $1.57B bet on UNH sparks investor interest, but soaring costs, weak earnings and legal woes still cloud recovery hopes.
UnitedHealth's Misdiagnosis: Can Berkshire's Bet Spark a Recovery?
Positive
Zacks Investment Research
1 day ago
UnitedHealth Invests in Behavioral Health: A Bet on Future Demand?
UNH expands behavioral health with Optum's digital tools, partnerships and integrated care to tap rising demand.
UnitedHealth Invests in Behavioral Health: A Bet on Future Demand?
Positive
Seeking Alpha
1 day ago
UnitedHealth: 2026 Repricing Will Be A Game Changer
UNH's stock collapse is a rare blue-chip event, driven by temporary cost spikes and cyclical headwinds, not a broken business model. Insider and smart money buying—including Berskshire Hathaway's $1.6B stake—signals deep value and a contrarian opportunity at current depressed valuations. Optum's vertical integration and earnings power create a moat; at current prices, I believe the insurance business is essentially free.
UnitedHealth: 2026 Repricing Will Be A Game Changer
Positive
Forbes
1 day ago
UnitedHealth: UNH Stock To $600?
With Warren Buffett's endorsement renewing investor confidence, the debate shifts from how low UnitedHealth stock could fall to how high it might rebound. At roughly 12 times trailing adjusted earnings versus a three-year average of 25 times, a climb from around $300 to above $600 is plausible—levels the stock touched just a few months ago, before things went south.
UnitedHealth: UNH Stock To $600?
Positive
Business Insider
2 days ago
Buffett watchers cheer Berkshire's Apple and UnitedHealth bets — but wonder why he's sitting on so much cash
Warren Buffett's Berkshire Hathaway rejigged its portfolio and grew its cash pile last quarter. Close watchers of the company praised its UnitedHealth investment and sales of Apple stock.
Buffett watchers cheer Berkshire's Apple and UnitedHealth bets — but wonder why he's sitting on so much cash
Positive
The Motley Fool
2 days ago
Prediction: 3 Magnificent Stocks That'll Be Worth More Than Palantir by 2028
Despite its recent pullback, Palantir Technologies (PLTR 1.60%) still ranks as one of the hottest stocks on the market this year. Some investors are no doubt mulling over whether or not to buy on the dip.
Prediction: 3 Magnificent Stocks That'll Be Worth More Than Palantir by 2028
Charts implemented using Lightweight Charts™